%0 Journal Article %J The lancet. HIV %D 2014 %T Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial. %A Sierra-Madero, Juan G %A Ellenberg, Susan S %A Rassool, Mohammed S %A Tierney, Ann %A Belaunzarán-Zamudio, Pablo F %A López-Martínez, Alondra %A Piñeirúa-Menéndez, Alicia %A Montaner, Luis J %A Azzoni, Livio %A Benítez, César Rivera %A Sereti, Irini %A Andrade-Villanueva, Jaime %A Mosqueda-Gómez, Juan L %A Rodriguez, Benigno %A Sanne, Ian %A Lederman, Michael M %N 2 %P e60-7 %R 10.1016/S2352-3018(14)70027-X %V 1 %X Immune reconstitution inflammatory syndrome (IRIS) is a common complication of antiretroviral therapy (ART) in patients with HIV. IRIS is associated with an increased risk of admission to hospital and death. We assessed whether CCR5 blockade with maraviroc reduces the risk of IRIS. %8 2014 Nov